BARBIERI LINDA

Ochoa, E., Morelli, L., Salvioni, L., Giustra, M., De Santes, B., Spena, F., et al. (2024). Co-processed materials testing as excipients to produce Orally Disintegrating Tablets (ODT) using binder jet 3D-printing technology. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 194(January 2024), 85-94 [10.1016/j.ejpb.2023.11.023]. Dettaglio

Morelli, L., Ochoa, E., Salvioni, L., Davide Giustra, M., De Santes, B., Spena, F., et al. (2024). Microfluidic nanoparticle synthesis for oral solid dosage forms: A step toward clinical transition processes. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 652(5 March 2024) [10.1016/j.ijpharm.2024.123850]. Dettaglio

(2023). Exploiting H-ferritin nanoconjugates to improve cancer immunotherapy and drugs delivery. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2023). Dettaglio

Rotem, R., Bertolini, J., Salvioni, L., Barbieri, L., Rizzuto, M., Tinelli, V., et al. (2023). Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2. NANOMEDICINE, 47(January 2023) [10.1016/j.nano.2022.102626]. Dettaglio

Sevieri, M., Mazzucchelli, S., Barbieri, L., Garbujo, S., Carelli, S., Bonizzi, A., et al. (2023). Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis. PHARMACOLOGICAL RESEARCH, 196(October 2023), 1-12 [10.1016/j.phrs.2023.106934]. Dettaglio